These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 33290599)

  • 21. Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months.
    Messer LH; Berget C; Vigers T; Pyle L; Geno C; Wadwa RP; Driscoll KA; Forlenza GP
    Pediatr Diabetes; 2020 Mar; 21(2):319-327. PubMed ID: 31885123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A remote monitoring system for artificial pancreas support is safe, reliable, and user friendly.
    Oron T; Farfel A; Muller I; Miller S; Atlas E; Nimri R; Phillip M
    Diabetes Technol Ther; 2014 Nov; 16(11):699-705. PubMed ID: 25211216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4).
    Ziegler C; Liberman A; Nimri R; Muller I; Klemenčič S; Bratina N; Bläsig S; Remus K; Phillip M; Battelino T; Kordonouri O; Danne T; Lange K
    J Diabetes Res; 2015; 2015():590308. PubMed ID: 26581230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients' perception and future acceptance of an artificial pancreas.
    van Bon AC; Kohinor MJ; Hoekstra JB; von Basum G; deVries JH
    J Diabetes Sci Technol; 2010 May; 4(3):596-602. PubMed ID: 20513325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing patient-reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures.
    Weissberg-Benchell J; Shapiro JB; Hood K; Laffel LM; Naranjo D; Miller K; Barnard K
    Diabet Med; 2019 May; 36(5):644-652. PubMed ID: 30761592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living with sensor-augmented pump therapy in type 1 diabetes: adolescents' and parents' search for harmony.
    Rashotte J; Tousignant K; Richardson C; Fothergill-Bourbonnais F; Nakhla MM; Olivier P; Lawson ML
    Can J Diabetes; 2014 Aug; 38(4):256-62. PubMed ID: 25023738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient Values and Preferences Regarding Continuous Subcutaneous Insulin Infusion and Artificial Pancreas in Adults with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Data.
    Muñoz-Velandia O; Guyatt G; Devji T; Zhang Y; Li SA; Alexander PE; Henao D; Gomez AM; Ruiz-Morales Á
    Diabetes Technol Ther; 2019 Apr; 21(4):183-200. PubMed ID: 30839227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Closed-loop glucose control: psychological and behavioral considerations.
    Gonder-Frederick L; Shepard J; Peterson N
    J Diabetes Sci Technol; 2011 Nov; 5(6):1387-95. PubMed ID: 22226256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
    Foster NC; Beck RW; Miller KM; Clements MA; Rickels MR; DiMeglio LA; Maahs DM; Tamborlane WV; Bergenstal R; Smith E; Olson BA; Garg SK
    Diabetes Technol Ther; 2019 Feb; 21(2):66-72. PubMed ID: 30657336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review.
    Alsaleh FM; Smith FJ; Taylor KM
    J Clin Pharm Ther; 2012 Apr; 37(2):140-7. PubMed ID: 21729118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial pancreas (AP) clinical trial participants' acceptance of future AP technology.
    Bevier WC; Fuller SM; Fuller RP; Rubin RR; Dassau E; Doyle FJ; Jovanovič L; Zisser HC
    Diabetes Technol Ther; 2014 Sep; 16(9):590-5. PubMed ID: 24811147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experiences in Sensor-Augmented Pump Therapy in Families with two Children with Type 1 diabetes: A Qualitative Study.
    Bomba F; Müller-Godeffroy E; von Sengbusch S
    Exp Clin Endocrinol Diabetes; 2018 Mar; 126(3):162-167. PubMed ID: 28750428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reexamining the Hypoglycemia Fear Survey for Parents of Young Children in a Sample of Children Using Insulin Pumps.
    Patton SR; Noser AE; Clements MA; Dolan LM; Powers SW
    Diabetes Technol Ther; 2017 Feb; 19(2):103-108. PubMed ID: 28118046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system.
    Ekhlaspour L; Forlenza GP; Chernavvsky D; Maahs DM; Wadwa RP; Deboer MD; Messer LH; Town M; Pinnata J; Kruse G; Kovatchev BP; Buckingham BA; Breton MD
    Pediatr Diabetes; 2019 Sep; 20(6):759-768. PubMed ID: 31099946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'I was ready for it at the beginning': Parent experiences with early introduction of continuous glucose monitoring following their child's Type 1 diabetes diagnosis.
    Tanenbaum ML; Zaharieva DP; Addala A; Ngo J; Prahalad P; Leverenz B; New C; Maahs DM; Hood KK
    Diabet Med; 2021 Aug; 38(8):e14567. PubMed ID: 33772862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrated multivariable artificial pancreas control system.
    Turksoy K; Quinn LT; Littlejohn E; Cinar A
    J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.